PEYMAN PAHLAVAN: Open Payments
NPI 1063450757 · MELROSE PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 54 payments from 15 companies in 2025. Trend: 2023 $2,928 · 2024 $2,587 · 2025 $1,891
Food & beverage: $1,891
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $337 |
| Lilly USA, LLC | 5 | $207 |
| Novo Nordisk Inc | 11 | $203 |
| ABBVIE INC. | 8 | $188 |
| Boston Scientific Corporation | 2 | $158 |
| GlaxoSmithKline, LLC. | 3 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $143 |
| Medtronic, Inc. | 2 | $142 |
| Phathom Pharmaceuticals, Inc. | 2 | $133 |
| Abbott Laboratories | 3 | $65 |
Products named: VRAYLAR, AIRSUPRA, SpyGlass Discover, Kerendia, SIGNIA, VOQUEZNA, BREZTRI, AREXVY.
Industry payments across IL — which companies pay providers there.
